# Bernhard Ludvik

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bernhard-ludvik/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,366 |
| Field | Diabetes Treatment and Management |
| h-index | 55 |
| i10-index | 132 |
| Last Known Institution | Clinical Trial Investigators |
| OpenAlex ID | https://openalex.org/A5071354955 |
| ORCID iD | 0000-0001-9843-9385 |
| Works | 280 |

## Researcher papers

- [Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone](https://scholariq.org/papers/improvement-in-glucose-tolerance-and-insulin-resistance-in-obese-subjects/)
- [3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial](https://scholariq.org/papers/3-years-of-liraglutide-versus-placebo-for-type-2-diabetes-risk-reduction-and/)
- [A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test](https://scholariq.org/papers/a-model-based-method-for-assessing-insulin-sensitivity-from-the-oral-glucose/)
- [Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial](https://scholariq.org/papers/once-weekly-tirzepatide-versus-once-daily-insulin-degludec-as-add-on-to/)
- [Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels](https://scholariq.org/papers/sleeve-gastrectomy-and-gastric-banding-effects-on-plasma-ghrelin-levels/)
- [Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin](https://scholariq.org/papers/sleeve-gastrectomy-as-sole-and-definitive-bariatric-procedure-5-year-results-for/)
- [The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus](https://scholariq.org/papers/the-relative-benefits-of-endurance-and-strength-training-on-the-metabolic/)
- [Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial](https://scholariq.org/papers/semaglutide-once-weekly-as-add-on-to-sglt-2-inhibitor-therapy-in-type-2-diabetes/)
- [CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity](https://scholariq.org/papers/cc-chemokine-and-cc-chemokine-receptor-profiles-in-visceral-and-subcutaneous/)
- [Increased Plasma Visfatin Concentrations in Morbidly Obese Subjects Are Reduced after Gastric Banding](https://scholariq.org/papers/increased-plasma-visfatin-concentrations-in-morbidly-obese-subjects-are-reduced/)
- [Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease](https://scholariq.org/papers/semaglutide-and-hospitalizations-in-patients-with-obesity-and-established/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [Clinical Trial Investigators](https://scholariq.org/institutions/clinical-trial-investigators/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.